1. Terry Gernsheimer,Keith McCrae (2007). Immune thrombocytopenic purpura in pregnancy. Current Opinion in Hematology, 14(5), 574-580.
2. S. Sainio,R. Kekomaki,S. Riikonen (2000). Maternal thrombocytopenia at term: a population‐based study. Acta Obstetricia et Gynecologica Scandinavica, 79(9), 744-749.
3. Robert Burrows,John Kelton (1990). Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. American Journal of Obstetrics and Gynecology, 163(4), 1147-1150.
4. Françoise Boehlen,Patrick Hohlfeld,Philippe Extermann,Thomas Perneger,Philippe de Moerloose (2000). Platelet Count at Term Pregnancy. Obstetrics & Gynecology, 95(1), 29-33.
5. H. Minakami,T. Kuwata,I. Sato (1996). Gestational thrombocytopenia: is it new?. Am J Obstet Gynecol, 175, 1676-167.
6. Page Abrahamson,Susan Hall,Maurille Feudjo‐tepie,Fanny Mitrani‐gold,John Logie (2009). The incidence of idiopathic thrombocytopenic purpura among adults: a population‐based study and literature review. European Journal of Haematology, 83(2), 83-89.
7. W. Schoonen,G. Kucera,J. Coalson,L. Li,M. Rutstein,F. Mowat (2009). Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol, 145, 235-244.
8. K. McCrae,D. Cines (1997). Thrombotic microangiopathy during pregnancy. Semin Hematol, 34, 148-158.
9. C. Weiner (1987). Thrombotic microangiopathy in pregnancy and the post-partum period. Semin Hematol, 24, 119-129.
10. R. Schneppenheim,U. Budde,F. Oyen,D. Angerhaus,V. Aumann (2003). Von Willebrand factor cleaving protease and ADAMTS13 mutations in childwood TTP. Blood, 101, 1845-18.
11. W. Bell,H. Braine,P. Ness,T. Kichler (1991). Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome.
12. G. Rock,K. Shumak,N. Buskard,V. Blanchette,J. Kelton (1991). Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine, 325(6), 393-397.
13. P. Coppo,A. Bussel,S. Charrier,C. Adrie,C. Alberti (2003). High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome. Medicine, 82(1), 27-38.
14. N. Novitzky,P. Jacobs (1994). The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange?. Br. J. Haematol, 87, 31.
15. M. Furlan,R. Robles,B. Morselli,P. Sandoz,B. (1999). Lämml Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura Thromb. Hae-most, 81, 8-13.
16. G. (1987). Del Zoppo Antiplatelet therapy in thrombotic thrombocytopenic purpura Semin. Hematol, 24(1987), 130-13.
17. V. Roy,M. Rizvi,S. Vesely,J. George (2001). Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplantation, 27, 641-646.
18. T. Gaddis,T. Guthrie,M. Drew,M. Sahud,R. Howe,A. (1997). Mittelman Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. Am. J. Hematol, 55.
19. (2011). British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011. British Journal of Dermatology, 165(4), 711-734.
20. Nathalie Costedoat-Chalumeau,Zahir Amoura,Du Huong,Philippe Lechat,Jean-Charles Piette (2005). Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmunity Reviews, 4(2), 111-115.
21. Eliza Chakravarty,Elaine Murray,Ariella Kelman,Pamela Farmer (2011). Pregnancy outcomes after maternal exposure to rituximab. Blood, 117(5), 1499-1506.
22. Paul Imbach,Mark Crowther (2011). Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia. New England Journal of Medicine, 365(8), 734-741.
23. Donald Harkness,J. Byrnes,E. Lian,W. Williams,G. (1981). Hazard of platelet transfusion in thrombotic thrombocytopenic purpur. JAMA, 246(17)
24. A. Creager,M. Brecher,N. Bandarenko (1998). Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion, 38(5), 419-423.
25. (2003). Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology, 120(4), 574-596.
26. J. George,S. Woolf,G. Raskob,J. Wasser,L. Aledort (1996). Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]. Blood, 88(1), 3-40.
27. K. Webert,R. Mittal,C. Sigouin,N. Heddle (2003). A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood, 102, 4306-4431.
28. A. Valat,M. Caulier,P. Devos,L. Rugeri,B. Wibaut (1998). Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocy-topenia. Br J Haematol, 103, 397-40.
29. H. Iyori,K. Fujisawa (1997). Thrombocytopenia in Neonates Born to Women with Autoimmune Thrombocytopenic Purpura. Pediatric Hematology and Oncology, 14(4), 367-373.
30. Karamjit Gill,John Kelton (2000). Management of idiopathic thrombocytopenic purpura in pregnancy. Seminars in Hematology, 37(3), 275-289.
31. D. Provan,R. Stasi,A. Newland,V. Blanchette,P. Bolton-Maggs (2010). International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115(2), 168-186.
32. R. Ali,F. Ozkalemkas,T. Ozcelik,V. Ozkocaman,U. Ozan,neonatal Hematol (2003). Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes. Annals of Hematology, 82(6), 348-352.
33. Vanita Suri,Neelam Aggarwal,Shilpi Saxena,Pankaj Malhotra,Subhash Varma (2006). Maternal and perinatal outcome in idiopathic thrombocytopenic purpura (ITP) with pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 85(12), 1430-1435.
34. V. Loustau,L. Baili,M. Khellaf,L. Languille,P. Bierling,B. Haddad (2012). Influence de la grossesse sur l’évolution du purpura thrombopénique immunologique : analyse rétrospective de 80 grossesses. Rev Med Interne, 33
35. O. Debouverie,P. Roblot,F. Roy-Peaud,C. Boinot,F. Pierre,O. Pourrat (2011). Rev Med Interne, 32, S88.
36. Lorence Gutterman,T. Stevenson (1982). Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA, 247(10), 1433-143.
37. J. Welborn,P. Emrick,plasmapheresis Hematol (1990). Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis.
38. P. Wong,K. Itoh,S. (1986). Treatment of Thrombotic Thrombocytopenic Purpura with Intravenous Gamma Globulin. New England Journal of Medicine, 314(6), 385-386.
39. Jenniferm. Bird,David Cummins,Samuelj. Machin (1990). Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura. The Lancet, 336(8714), 565-566.
40. Mark Crowther,Nancy Heddle,Catherine Hayward,Theodore Warkentin,John Kelton (1996). Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. Annals of Internal Medicine, 125(4), 294-296.
41. M. Furlan,R. Robles,M. Galbusera,G. Remuzzi,P. Kyrle (1998). von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome. New England Journal of Medicine, 339(22), 1578-1584.
42. R. Yomtovian,W. Niklinski,B. Silver,R. Sarode (2004). Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
43. M. Rose,A. Eldor (1987). High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am. J. Med, 83, 437-44.
44. Jeffrey Patton,Kenneth Manning,Douglas Case,John Owen (1994). Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura. American Journal of Hematology, 47(2), 94-99.
45. X. Zheng,R. Kaufman,L. Goodnough,J. Effect Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.